Specialty Chemicals company Epigral announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: YoY Revenue grew by 20% to Rs 631 crore, on account of volume growth from Derivative products. Revenue contribution from Derivatives & Specialty business increased to 52% in Q4FY25 vs 48% in Q4FY24. EBITDA grew by 12% to Rs 173 crore vs Rs 155 crore in Q4FY24, and EBITDA margin stood at 28%. PAT rose by 13% to Rs 87 crore. ROCE grew to 25% as on 31st March 2025 vs 18% as on 31st March 2024 due to improvement in earnings. Net Debt/EBITDA significantly reduced to 0.7x as on 31st March 2025 vs 2.0x as on 31st March 2024 on account of improvement in EBITDA and reduction in net debt. FY25 Financial Highlights: Highest ever revenue of Rs 2,565 crore, growth of 33% on account of volume growth from Derivative products. Revenue contribution from Derivatives & Specialty business increased to 54% in FY25 vs 45% in FY24. EBITDA grew by 48% to Rs 711 crore vs Rs 481 crore in FY24. EBITDA margin stood at 28% in FY25 vs 25% in FY24 on account of a better product mix, led by contribution from new projects. PAT jumped by 82% to Rs 357 crore. Maulik Patel, Chairman and Managing Director, Epigral, said: “We ended FY25 with the highest ever revenue of Rs 2,565 crore, a growth of 33% compared to the previous year. This growth is on account of a volume rise of 11%, majorly from high-value products. Derivatives & Specialty business volume grew by around 24% in FY25, and its contribution to revenue touched 54% compared to 45% in FY24. Considering the growth opportunity, we further announced expanding our CPVC and Epichlorohydrin capacity, which are expected to be commissioned in the first half of FY27 and will contribute from FY27 onwards. Once these projects reach optimum utilisation, our integrated complex will further strengthen. We are geared up and strengthened our position, to grow further, by focusing on import substitute products, further diversifying and increasing Derivatives & Specialty business and with prudence allocation of capital, rewarding our stakeholders.” Result PDF